心肌營(yíng)養(yǎng)素1(CT1)多克隆抗體
Polyclonal Antibody to Cardiotrophin 1 (CT1)
CTF1
- 編號(hào)UPAA810Mu02
- 物種Mus musculus (Mouse，小鼠) 相同的名稱，不同的物種。
- 來源多抗制備
- 宿主兔
- 效價(jià)-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標(biāo)記物無標(biāo)記物
- 免疫原 -
- 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
- 性狀液體
- 濃度500μg/mL
- 且適物種-
- 應(yīng)用WB; IHC; ICC; IP.
如果抗體需用于流式細(xì)胞術(shù)，請(qǐng)參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價(jià)格 ¥ 292 ¥ 680 ¥ 972 ¥ 2430 ¥ 9720
- 欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
特異性
該抗體是針對(duì)CT1的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識(shí)別CT1。
用法
免疫印跡：0.2-2μg/mL;1:250-2500
免疫組織化學(xué)：5-20μg/mL;1:25-100
免疫細(xì)胞化學(xué)：5-20μg/mL;1:25-100
最佳稀釋倍數(shù)最終由用戶決定。
儲(chǔ)存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。
贈(zèng)品
增值服務(wù)
抗體標(biāo)記定制服務(wù)
Protein-A/G純化柱
細(xì)胞和組織染色液
抗體陽性對(duì)照品
組織/切片定制服務(wù)
磷酸化抗體定制服務(wù)
免疫印跡(WB)實(shí)驗(yàn)服務(wù)
免疫組織化學(xué)(IHC)實(shí)驗(yàn)服務(wù)
免疫細(xì)胞化學(xué)(ICC)實(shí)驗(yàn)服務(wù)
流式細(xì)胞術(shù)(FCM)實(shí)驗(yàn)服務(wù)
免疫沉淀(IP)實(shí)驗(yàn)服務(wù)
免疫熒光(IF)實(shí)驗(yàn)服務(wù)
緩沖液
DAB顯色試劑盒
SABC試劑盒
長(zhǎng)臂生物素標(biāo)記試劑盒
實(shí)時(shí)熒光定量PCR實(shí)驗(yàn)服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Mus musculus (Mouse，小鼠) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| URPA810Mu01 | 心肌營(yíng)養(yǎng)素1(CT1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UAPA810Mu01 | 心肌營(yíng)養(yǎng)素1(CT1)活性蛋白 | Cell?culture;?Activity?Assays. |
| URPA810Mu02 | 心肌營(yíng)養(yǎng)素1(CT1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UPAA810Mu01 | 心肌營(yíng)養(yǎng)素1(CT1)多克隆抗體 | WB; IHC; ICC; IP. |
| UPAA810Mu02 | 心肌營(yíng)養(yǎng)素1(CT1)多克隆抗體 | WB; IHC; ICC; IP. |
| USEA810Mu | 心肌營(yíng)養(yǎng)素1(CT1)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| ULMA810Mu | 心肌營(yíng)養(yǎng)素1(CT1)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| European Journal of Preventive Cardiology | Exercise rescued chronic kidney disease by attenuating cardiac hypertrophy through the cardiotrophin-1 -> LIFR/gp 130 -> JAK/STAT3 pathway. [PubMed: 23064267] |
| Journal of Hypertension | Is There Any Additional Cardiotrophin 1 Increase With Obesity in Hypertensive Patients?: Pp. 12.466 [Lww: Source] |
| Journal of Hypertension | Cardiotrophyn 1 Levels in Nondipper Hypertensive Patients: Pp. 12.464 [Lww: Source] |
| American Journal of Hypertension | Association Between Cardiotrophin 1 Levels and Central Blood Pressure in Untreated Patients With Essential Hypertension [Pubmed: 24401751] |
| Scientific Reports | Biomarkers and Echocardiographic Predictors of Myocardial Dysfunction in Patients with Hypertension [PubMed: 25747153] |
| Int J Mol Sci | The Multi-Biomarker Approach for Heart Failure in Patients with Hypertension [PubMed: 25984599] |
| Food & Function | Pterostilbene improves glycaemic control in rats fed an obesogenic diet: involvement of skeletal muscle and liver [PubMed: 25998070] |
| International journal of cardiology | Differences in biochemical and genetic biomarkers in patients with heart failure of various etiologies. [pubmed:27448535] |
| Soldan sa?a ?antl? do?umsal kalp hastal?kl? ?ocuklarda ?ant miktar? ile kardiyotrofin–1 ili?kisi [Doi: 10.5505/deutfd.2018.25338.30074] | |
| Annals?of?Nutrition?and?Metabolism | Effect of Salt Intake on the Serum Cardiotrophin-1 Levels in Chinese Adults [Pubmed: 30408810] |
| Atherosclerotic diseases | Cardiotrophin-1 and leptin as cardiovascular risk markers in male patients with obstructive sleep apnea syndrome [Pubmed: 30775602] |
